About
About US
Company Overview
History
Location
Technology
Platform Technology Introduction
SelecAll™
Albubody™
Intellectual Property
Pipeline
Pipeline overview
PAT101
PAT205/206
PR/IR
News
Partners
Resource
Board/Notice
Resource
KOR
Pipeline
Pipeline
About
Technology
Pipeline
PR/IR
Resource
Pipeline overview
Pipeline overview
PAT101
PAT205/206
Pineline Overview
Platfrom
Program
Active Substance
Disease
R&D
Non-Clinical
Phase 1
Phase 2
Selec
All™
PAT101
PAT205/206
Uox-HSA
(Urate Oxidase)
GLP1
Refrctory
Tophaceous Gout
Obesity
Open Innovation
Albubody
™
PAT301
PAT401
Albubody-
Drug conjugate
LYTACs
Anti-Cancer
Anti-Cancer
Open Innovation
Platfrom
Program
Active Substance
Disease
Selec
All™
PAT101
PAT205/206
Uox-HSA
(Urate Oxidase)
GLP1
Refrctory
Tophaceous Gout
Obesity
Albu
body™
PAT301
PAT401
Albubody-
Drug conjugate
LYTACs
Anti-Cancer
Anti-Cancer
R&D
Non-Clinical
Phase 1
Phase 2
Open Innovation
Open Innovation
KOR
About
About US
Company Overview
History
Location
Technology
Platform Technology Introduction
SelecAll™
Albubody™
Intellectual Property
Pipeline
Pipeline overview
PAT101
PAT205/206
PR/IR
News
Partners
Resource
Board/Notice
Resource